MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Mitochondrial dysfunction"

  • MDS Virtual Congress 2020

    Perillyl alcohol restores mitochondrial dysfunction and abridge NLRP3 inflammasomes activation in in-vitro and in-vivo model of Parkinson’s disease

    P. Panda, S. Ahmed, V. Naidu (Kamrup, India)

    Objective: Parkinson's disease (PD) affects around 2-3% population of age greater than 65 and is the second most common neurogenerative disorder. The molecular mechanism underpinning…
  • MDS Virtual Congress 2020

    PARK2 p.Ala82Glu variant is not associated with Parkinson’s disease

    L. Milanowski, B. Broadway, F. Fiesel, D. Hoffman-Zacharska, D. Koziorowski, A. Friedman, J. Slawek, O. Ross, W. Springer, Z. Wszolek (Jacksonville, FL, USA)

    Objective: The aim of the study was to analyze potential pathogenicity of the PARK2 p.Ala82Glu mutation, by functional studies of Parkin in the mitophagy paradigm…
  • MDS Virtual Congress 2020

    Loss of CHCHD2 and CHCHD10 disrupts mitochondrial cristae phenocopying patient mutations

    D. Narendra, Y. Liu, X. Huang, D. Nguyen, M. Shammas, B. Wu, E. Dombi, D. Springer, J. Poulton, S. Sekine (Bethesda, MD, USA)

    Objective: Characterization of novel of a novel CHCHD2 (C2) and CHCHD10 (C10) knockout mouse model. Background: Dominant mutations in the mitochondrial paralogs CHCHD2 (C2) and…
  • MDS Virtual Congress 2020

    Poly-ADP-ribose polymerase 1 modulates mitochondrial fission via LRRK2 in a rotenone-induced Parkinson’s disease model

    L. Bu, Y. Lu, Y. Liang, Y. Chen, S. Peng (Guangzhou, China)

    Objective: To clarity the effects and mechanism of poly-ADP-ribose polymerase 1(PARP1) in regulating mitochondrial fusion/fission in a rotenone-induced Parkinson's disease (PD) model. Background: Accumulating evidences…
  • MDS Virtual Congress 2020

    Mutations of COX20 affect the assembly and function of complex IV causing early onset ataxia, dystonia and neuropathy

    Y.M Liu, P.Z Li, DD. Guo, H.B LV, Y.L Zhang (Jinan, China)

    Objective: To find the causes of an early onset complex movement disorder in two sisters from a non-consanguineous family, and confirm the COX20 variants responsible for such mitochondrial…
  • 2019 International Congress

    Using cognitive computing to identify existing drugs with potential to stabilize mitophagy pathways associated with Parkinson’s Disease

    N. Visanji, N. Moskal, G. Shi, A. Lacoste, S. Spangler, P. Lewis, A. Mcquibban (Toronto, ON, Canada)

    Objective: We applied IBM Watson for Drug Discovery (WDD), a cognitive computing platform that uses natural language processing, to identify compounds with the potential to…
  • 2019 International Congress

    Another mitochondrial disease mimic: Two Case reports of adult riboflavin transporter deficiency (RTD) type 2 with muscle adenosine monophosphate (AMP) deaminase deficiency

    L. Zhang, D. Thyagarajan (Melbourne, Australia)

    Objective: To present two rare cases of RTD type 2 with co-existing AMP deaminase deficiency. Background: RTD, formerly known as Brown-Vialetto-Van Laere syndrome, is a…
  • 2019 International Congress

    Arm levitation as an early manifestation in MELAS syndrome: A case report

    D. Gunal, I. Midi, E. Erdil (Istanbul, Turkey)

    Objective: Arm levitation in MELAS  syndrome Background: MELAS syndrome has broad manifestations including stroke-like episodes, dementia, epilepsy, lactic academia, myopathy, recurrent headaches, hearing impairment, diabetes and short…
  • 2019 International Congress

    A coding VPS13C haplotype is associated with reduced risk for Parkinson disease

    U. Rudakou, J. Ruskey, L. Krohn, S. Laurent, D. Spiegelman, L. Greenbaum, G. Yahalom, A. Desautels, J. Montplaisir, S. Fahn, C. Waters, L. Levy, C. Kehoe, S. Narayan, Y. Dauvilliers, N. Dupré, S. Hassin-Baer, R. Alcalay, G. Rouleau, E. Fon, Z. Gan-Or (Montreal, QC, Canada)

    Objective: To study the role of coding VPS13C variants in a large cohort of late-onset PD (LOPD) patients. Background: VPS13C is within a risk locus…
  • 2019 International Congress

    Detecting unsuspected mitochondrial disease: an algorithmic approach

    N. Pulley, C. Condon, I. Haq (Winston-Salem, NC, USA)

    Objective: To present an algorithmic approach to the diagnosis of mitochondrial disease for clinical neurologists Background: Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS Syndrome)…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 12
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley